DealsGoldman Sachs to acquire NorgineGoldman Sachs is acquiring a majority stake in Norgine, a European specialty pharmaceutical firm.ByIris Dorbian27 May 2022•4 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs